BIOARRAY joins CERTANIA Group

Spanish Genetic Diagnostics Pioneer Becomes Part of CERTANIA’s Expanding Global Network

Elche/Munich, July 09, 2025 – Bioarray, a leading Spanish diagnostic and research laboratory specializing in advanced genetic testing, is pleased to announce its integration into CERTANIA, a dynamic group specializing in Testing, Inspection, and Certification (TIC) services. This strategic partnership marks an exciting milestone for Bioarray, enhancing its ability to deliver cutting-edge genomic diagnostics to an even broader range of clinical and research partners worldwide.

Founded in 2009 and headquartered in Elche (Alicante), Spain, Bioarray has established itself as a trusted provider of high-value genetic testing services, combining scientific excellence with technological innovation. The company specializes in molecular diagnostics using technologies such as array-CGH and Next Generation Sequencing (NGS), supporting a wide array of applications in reproductive genetics, oncology, and clinical medicine. Bioarray also serves as a strong partner in genomic research, offering services such as gene expression studies, RNA-sequencing, and customized bioinformatics solutions.

With operations in Europe, Latin America, and the MENA region, Bioarray serves clients in over 40 countries. Its international presence is complemented by long-standing relationships with public hospitals, private healthcare providers, fertility clinics, and research institutions.

By joining CERTANIA, Bioarray will benefit from a strong international platform to accelerate its growth, expand its service offerings, and strengthen its global reach in the genetic diagnostics market. The collaboration will open new opportunities for innovation and cross-border synergies while preserving Bioarray’s scientific expertise and entrepreneurial culture.

Andrés Antón Salas, cofounder and General Manager of Bioarray, will continue to lead the company. “Joining CERTANIA is a natural next step for Bioarray. It allows us to maintain our independence and identity while gaining access to the tools and support we need to scale and innovate,” said Antón. “We’re excited to contribute our genetic diagnostics expertise to the broader CERTANIA network and continue delivering impactful solutions for patients and research partners.”

Karsten Xander, CEO and founder of CERTANIA, emphasized the strategic fit of this partnership: “Bioarray brings cutting-edge genetic testing capabilities to CERTANIA, significantly enhancing our presence in life sciences and clinical diagnostics. Their innovation-driven mindset and international outlook align perfectly with our mission to build a group of exceptional, specialized companies united by quality and scientific excellence.”

CERTANIA’s investment in Bioarray reflects the group’s commitment to expanding its portfolio in medical diagnostics and life sciences, enabling sustainable growth, cross-sector collaboration, and knowledge exchange across its member companies.

CERTANIA provides a platform for mid-sized, knowledge-based companies to thrive under one umbrella, maintaining entrepreneurial freedom while benefiting from group resources and support.

About Bioarray: Headquartered in Elche (Alicante), Spain, Bioarray is a diagnostic and research laboratory specializing in advanced genetic analysis for the healthcare, biotechnology, and research sectors. The company offers a broad range of services, including prenatal and reproductive testing, oncology diagnostics, and research genomics. Bioarray also supports labs globally through its sister company, Journey Genomics, which developed PGD-Seq™, a kit for NGS-based preimplantation testing. For more information, visit bioarray.es.

About CERTANIA: Under the umbrella of CERTANIA Holding GmbH, a new global market player is created in the field of Testing, Inspection & Certification as well as scientific, laboratory and compliance services. This group offers medium-sized partners a sustainable home for their life’s work. CERTANIA enables entrepreneurs and owners to further develop their companies with like-minded people, while continuing to preserve their entrepreneurial roots, corporate culture, brand, and values. For more information, visit certania.com.